The iPlate™
'Where there is a need, there is opportunity'
Investment Opportunity
Vaccines, Medicine, and Health Care issues have been at the forefront of everyone's mind in the world since the beginning of 2020 with the discovery of the Coronavirus. We are now dealing with considerably more contagious variants that will continue to adapt and mutate, placing an even higher demand on vaccine development.
The industry is in desperate need of laboratory efficiency, lab automation, and is making sizable investments in life science initiatives for rapid drug discovery. The desire for screening technologies with reduced cost and turnaround time is absolute.
With many advances in the Health Care and Life Sciences industry, there is one area where there has been no advances at all...
That is in the area of Blood Testing
Introducing the iFluidics iPlate™
Cost Saving using the iPlate™
Case Study
Typical Blood Bank • 130,000 tests per year
Our Primary Market is Microplates
Worldwide, labs consume over 200 million microplates annually.
Our initial Market Strategy is to capture 2% of the Market.
This would generate a Return on Investment of 10X
The long term expectation is to get a much higher return
iFluidics Growth Strategy
